Vincent Ossipow

Partner

2014 - Current

Partner at Omega Funds

2014

Partner

2014 - 2017

Chief Scientific Officer (CSO)

2021

Member of the Board of Directors

2007

Current Board Seats: -Aerium Therapeutics (USA-Switzerland, private), Board Director -Immunic (USA, NASDAQ listed), Board Director, Chairman of the Nomination Committee, prior member of the Audit Committee, prior member of the Remuneration Committee -Bioinvent (Sweden, publicly listed), Board Director, member of the Nomination Committee, prior member of the Audit Committee -Sophia Genetics (Switzerland, NASDAQ listed), Independent Board Director, member of the Remuneration Committee -Etherna Immuno-Oncology (Belgium, private), Chairman of the Audit Committee, Board Director -FoRx (Switzerland, private), Board Director, member of the Nomination Committee -Anaconda Brain (Spain, private), Board observer Prior Board of Director experience: -Andrew Alliance (Switzerland, private), Board Director, member of the Remuneration Committee. Acquired -LifeSpan (USA, private), Board Director. Acquired -Raindance Technologies (USA, private), Board Director. Acquired -Kuros Biosciences (Switzerland, publicly traded), Board Director, Chairman of the Audit Committee -Endosense (Switzerland, private), Board observer. Acquired

Partner Private Equity

2012 - 2013

Investment Manager

2007 - 2012

Faculty Member

2000 - 2007

Financial Analyst

1998 - 2000

Postdoctoral Fellow

1997 - 1998